According to this study, the global Clinical Trial Imaging market size will reach US$ 2482 million by 2031.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:

Technological progress: innovation drives core growth

High-precision and multimodal imaging technology

Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation

AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging

Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment

Improvement of regulatory framework

FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives

Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure

Aging and chronic disease burden

High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion

Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

LPI (LP Information)' newest research report, the “Clinical Trial Imaging Industry Forecast” looks at past sales and reviews total world Clinical Trial Imaging sales in 2024, providing a comprehensive analysis by region and market sector of projected Clinical Trial Imaging sales for 2025 through 2031. With Clinical Trial Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Trial Imaging industry.

This Insight Report provides a comprehensive analysis of the global Clinical Trial Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Trial Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Trial Imaging market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Trial Imaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Trial Imaging.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Trial Imaging market by product type, application, key players and key regions and countries.

Segmentation by Type:

    In-house Imaging Service

    Central Imaging Service

Segmentation by Application:

    Pharmaceutical Companies

    Biotechnology Companies

    Academic Institutes

    Others

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

    UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    ICON

    ERT

    McLaren

    Bioclinica

    Parexel

    BioTelemetry

    ProScan Imaging

    Imaging Endpoints

    Radiant Sage

    Micron, Inc.

    Intrinsic Imaging

    Median Technologies

    Cardiovascular Imaging Technologies

    Banook Medical

    IXICO

    Tigermed

    Runda Medical

    Konica Minolta

    Keosys

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Clinical Trial Imaging Market Size (2020-2031)
        2.1.2 Clinical Trial Imaging Market Size CAGR by Region (2020 VS 2024 VS 2031)
        2.1.3 World Current & Future Analysis for Clinical Trial Imaging by Country/Region (2020, 2024 & 2031)
    2.2 Clinical Trial Imaging Segment by Type
        2.2.1 In-house Imaging Service
        2.2.2 Central Imaging Service
    2.3 Clinical Trial Imaging Market Size by Type
        2.3.1 Clinical Trial Imaging Market Size CAGR by Type (2020 VS 2024 VS 2031)
        2.3.2 Global Clinical Trial Imaging Market Size Market Share by Type (2020-2025)
    2.4 Clinical Trial Imaging Segment by Application
        2.4.1 Pharmaceutical Companies
        2.4.2 Biotechnology Companies
        2.4.3 Academic Institutes
        2.4.4 Others
    2.5 Clinical Trial Imaging Market Size by Application
        2.5.1 Clinical Trial Imaging Market Size CAGR by Application (2020 VS 2024 VS 2031)
        2.5.2 Global Clinical Trial Imaging Market Size Market Share by Application (2020-2025)

3 Clinical Trial Imaging Market Size by Player
    3.1 Clinical Trial Imaging Market Size Market Share by Player
        3.1.1 Global Clinical Trial Imaging Revenue by Player (2020-2025)
        3.1.2 Global Clinical Trial Imaging Revenue Market Share by Player (2020-2025)
    3.2 Global Clinical Trial Imaging Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Clinical Trial Imaging by Region
    4.1 Clinical Trial Imaging Market Size by Region (2020-2025)
    4.2 Global Clinical Trial Imaging Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Clinical Trial Imaging Market Size Growth (2020-2025)
    4.4 APAC Clinical Trial Imaging Market Size Growth (2020-2025)
    4.5 Europe Clinical Trial Imaging Market Size Growth (2020-2025)
    4.6 Middle East & Africa Clinical Trial Imaging Market Size Growth (2020-2025)

5 Americas
    5.1 Americas Clinical Trial Imaging Market Size by Country (2020-2025)
    5.2 Americas Clinical Trial Imaging Market Size by Type (2020-2025)
    5.3 Americas Clinical Trial Imaging Market Size by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Clinical Trial Imaging Market Size by Region (2020-2025)
    6.2 APAC Clinical Trial Imaging Market Size by Type (2020-2025)
    6.3 APAC Clinical Trial Imaging Market Size by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Clinical Trial Imaging Market Size by Country (2020-2025)
    7.2 Europe Clinical Trial Imaging Market Size by Type (2020-2025)
    7.3 Europe Clinical Trial Imaging Market Size by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Clinical Trial Imaging by Region (2020-2025)
    8.2 Middle East & Africa Clinical Trial Imaging Market Size by Type (2020-2025)
    8.3 Middle East & Africa Clinical Trial Imaging Market Size by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Clinical Trial Imaging Market Forecast
    10.1 Global Clinical Trial Imaging Forecast by Region (2026-2031)
        10.1.1 Global Clinical Trial Imaging Forecast by Region (2026-2031)
        10.1.2 Americas Clinical Trial Imaging Forecast
        10.1.3 APAC Clinical Trial Imaging Forecast
        10.1.4 Europe Clinical Trial Imaging Forecast
        10.1.5 Middle East & Africa Clinical Trial Imaging Forecast
    10.2 Americas Clinical Trial Imaging Forecast by Country (2026-2031)
        10.2.1 United States Market Clinical Trial Imaging Forecast
        10.2.2 Canada Market Clinical Trial Imaging Forecast
        10.2.3 Mexico Market Clinical Trial Imaging Forecast
        10.2.4 Brazil Market Clinical Trial Imaging Forecast
    10.3 APAC Clinical Trial Imaging Forecast by Region (2026-2031)
        10.3.1 China Clinical Trial Imaging Market Forecast
        10.3.2 Japan Market Clinical Trial Imaging Forecast
        10.3.3 Korea Market Clinical Trial Imaging Forecast
        10.3.4 Southeast Asia Market Clinical Trial Imaging Forecast
        10.3.5 India Market Clinical Trial Imaging Forecast
        10.3.6 Australia Market Clinical Trial Imaging Forecast
    10.4 Europe Clinical Trial Imaging Forecast by Country (2026-2031)
        10.4.1 Germany Market Clinical Trial Imaging Forecast
        10.4.2 France Market Clinical Trial Imaging Forecast
        10.4.3 UK Market Clinical Trial Imaging Forecast
        10.4.4 Italy Market Clinical Trial Imaging Forecast
        10.4.5 Russia Market Clinical Trial Imaging Forecast
    10.5 Middle East & Africa Clinical Trial Imaging Forecast by Region (2026-2031)
        10.5.1 Egypt Market Clinical Trial Imaging Forecast
        10.5.2 South Africa Market Clinical Trial Imaging Forecast
        10.5.3 Israel Market Clinical Trial Imaging Forecast
        10.5.4 Turkey Market Clinical Trial Imaging Forecast
    10.6 Global Clinical Trial Imaging Forecast by Type (2026-2031)
    10.7 Global Clinical Trial Imaging Forecast by Application (2026-2031)
        10.7.1 GCC Countries Market Clinical Trial Imaging Forecast

11 Key Players Analysis
    11.1 ICON
        11.1.1 ICON Company Information
        11.1.2 ICON Clinical Trial Imaging Product Offered
        11.1.3 ICON Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.1.4 ICON Main Business Overview
        11.1.5 ICON Latest Developments
    11.2 ERT
        11.2.1 ERT Company Information
        11.2.2 ERT Clinical Trial Imaging Product Offered
        11.2.3 ERT Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.2.4 ERT Main Business Overview
        11.2.5 ERT Latest Developments
    11.3 McLaren
        11.3.1 McLaren Company Information
        11.3.2 McLaren Clinical Trial Imaging Product Offered
        11.3.3 McLaren Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.3.4 McLaren Main Business Overview
        11.3.5 McLaren Latest Developments
    11.4 Bioclinica
        11.4.1 Bioclinica Company Information
        11.4.2 Bioclinica Clinical Trial Imaging Product Offered
        11.4.3 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.4.4 Bioclinica Main Business Overview
        11.4.5 Bioclinica Latest Developments
    11.5 Parexel
        11.5.1 Parexel Company Information
        11.5.2 Parexel Clinical Trial Imaging Product Offered
        11.5.3 Parexel Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.5.4 Parexel Main Business Overview
        11.5.5 Parexel Latest Developments
    11.6 BioTelemetry
        11.6.1 BioTelemetry Company Information
        11.6.2 BioTelemetry Clinical Trial Imaging Product Offered
        11.6.3 BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.6.4 BioTelemetry Main Business Overview
        11.6.5 BioTelemetry Latest Developments
    11.7 ProScan Imaging
        11.7.1 ProScan Imaging Company Information
        11.7.2 ProScan Imaging Clinical Trial Imaging Product Offered
        11.7.3 ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.7.4 ProScan Imaging Main Business Overview
        11.7.5 ProScan Imaging Latest Developments
    11.8 Imaging Endpoints
        11.8.1 Imaging Endpoints Company Information
        11.8.2 Imaging Endpoints Clinical Trial Imaging Product Offered
        11.8.3 Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.8.4 Imaging Endpoints Main Business Overview
        11.8.5 Imaging Endpoints Latest Developments
    11.9 Radiant Sage
        11.9.1 Radiant Sage Company Information
        11.9.2 Radiant Sage Clinical Trial Imaging Product Offered
        11.9.3 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.9.4 Radiant Sage Main Business Overview
        11.9.5 Radiant Sage Latest Developments
    11.10 Micron, Inc.
        11.10.1 Micron, Inc. Company Information
        11.10.2 Micron, Inc. Clinical Trial Imaging Product Offered
        11.10.3 Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.10.4 Micron, Inc. Main Business Overview
        11.10.5 Micron, Inc. Latest Developments
    11.11 Intrinsic Imaging
        11.11.1 Intrinsic Imaging Company Information
        11.11.2 Intrinsic Imaging Clinical Trial Imaging Product Offered
        11.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.11.4 Intrinsic Imaging Main Business Overview
        11.11.5 Intrinsic Imaging Latest Developments
    11.12 Median Technologies
        11.12.1 Median Technologies Company Information
        11.12.2 Median Technologies Clinical Trial Imaging Product Offered
        11.12.3 Median Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.12.4 Median Technologies Main Business Overview
        11.12.5 Median Technologies Latest Developments
    11.13 Cardiovascular Imaging Technologies
        11.13.1 Cardiovascular Imaging Technologies Company Information
        11.13.2 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Offered
        11.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.13.4 Cardiovascular Imaging Technologies Main Business Overview
        11.13.5 Cardiovascular Imaging Technologies Latest Developments
    11.14 Banook Medical
        11.14.1 Banook Medical Company Information
        11.14.2 Banook Medical Clinical Trial Imaging Product Offered
        11.14.3 Banook Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.14.4 Banook Medical Main Business Overview
        11.14.5 Banook Medical Latest Developments
    11.15 IXICO
        11.15.1 IXICO Company Information
        11.15.2 IXICO Clinical Trial Imaging Product Offered
        11.15.3 IXICO Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.15.4 IXICO Main Business Overview
        11.15.5 IXICO Latest Developments
    11.16 Tigermed
        11.16.1 Tigermed Company Information
        11.16.2 Tigermed Clinical Trial Imaging Product Offered
        11.16.3 Tigermed Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.16.4 Tigermed Main Business Overview
        11.16.5 Tigermed Latest Developments
    11.17 Runda Medical
        11.17.1 Runda Medical Company Information
        11.17.2 Runda Medical Clinical Trial Imaging Product Offered
        11.17.3 Runda Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.17.4 Runda Medical Main Business Overview
        11.17.5 Runda Medical Latest Developments
    11.18 Konica Minolta
        11.18.1 Konica Minolta Company Information
        11.18.2 Konica Minolta Clinical Trial Imaging Product Offered
        11.18.3 Konica Minolta Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.18.4 Konica Minolta Main Business Overview
        11.18.5 Konica Minolta Latest Developments
    11.19 Keosys
        11.19.1 Keosys Company Information
        11.19.2 Keosys Clinical Trial Imaging Product Offered
        11.19.3 Keosys Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        11.19.4 Keosys Main Business Overview
        11.19.5 Keosys Latest Developments

12 Research Findings and Conclusion